.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Delivery within India

Delivery outside India

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

C3
Magazine
Markets
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Videos
Start-Up
Planet

Budget 2026
Magazine
Markets
OB Datalens
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Videos
Start-Up
Planet
Tech
Spotlight
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

C3
Magazine
Markets
Corporate
Economy & Policy
Newsletters
News
AI
Videos
Start-Up
Planet

home
Topic
Ranbaxysun pharmaceuticalsdilip sanghvidaiichi sankyodr reddys

RanbaxySun PharmaceuticalsDilip SanghviDaiichi SankyoDr Reddys

Sensex.

Markets Settle With Modest Gains In Highly Volatile Trade

BY Press Trust of India

Made in India Sputnik V Likely to be Available During Sept-Oct

Made in India Sputnik V Likely to be Available During Sept-Oct

BY PTI

Markets Close in Red; Sensex Skids 274 Pts

Market Intelligence

Markets Close in Red; Sensex Skids 274 Pts

BY PTI

Aster DM Healthcare Ties up with Dr Reddys to Administer Sputnik V

Aster DM Healthcare Ties up with Dr Reddy's to Administer Sputnik V

BY PTI

Apollo, Dr Reddys Collaborates for Covid Vaccination Programme With Sputnik V

Apollo, Dr Reddy's Collaborates for Covid Vaccination Programme With Sputnik V

BY PTI

Dr Reddys Laboratories Launches Cancer Treatment Drug Capecitabine In US

Dr Reddy's Laboratories Launches Cancer Treatment Drug Capecitabine In US

BY PTI

Sun Pharmaceuticals - A Specialty player

Sun Pharmaceuticals - A Specialty player

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2026 Outlook Publishing India Pvt Ltd.

Copyright © 2026 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.